Cas:89794-53-6 3-methoxy-cyclohexa-2,5-dienecarboxylic acid amide manufacturer & supplier

Chemical Name:3-methoxy-cyclohexa-2,5-dienecarboxylic acid amide

CAS.NO:89794-53-6

Synonyms:2,5-Cyclohexadiene-1-carboxamide,3-methoxy;3-methoxycyclohexanol;1,4-Dihydro-3-methoxybenzamid;3-Methoxy-cyclohexa-2,5-diencarbonsaeure-amid;3-MeO-cyclohexanol;3-methoxycyclohexan-1-ol

Molecular Formula:C₇H₁₄O₂

Molecular Weight:130.18500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:216.5ºC at 760 mmHg

Density:0.99g/cm3

Index of Refraction:1.457

PSA:29.46000

Exact Mass:130.09900

LogP:0.93630

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,5-Cyclohexadiene-1-carboxamide,3-methoxy chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-methoxycyclohexan-1-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-MeO-cyclohexanol Use and application,3-Methoxy-cyclohexa-2,5-diencarbonsaeure-amid technical grade,usp/ep/jp grade.

Related News: Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. 3-methoxy-cyclohexa-2,5-dienecarboxylic acid amide manufacturer But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US. 3-methoxy-cyclohexa-2,5-dienecarboxylic acid amide supplier Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. 3-methoxy-cyclohexa-2,5-dienecarboxylic acid amide vendor In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. 3-methoxy-cyclohexa-2,5-dienecarboxylic acid amide factory In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday.